| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Moradi David | CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner | 119 WASHINGTON AVE., SUITE 402, MIAMI BEACH | /s/ Christine G. Long, Attorney-in-Fact | 13 Jan 2026 | 0001658843 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AEYE | Common Stock | Tax liability | $197,649 | -20,849 | -2% | $9.48 | 1,009,486 | 09 Jan 2026 | Direct | F1 |
| holding | AEYE | Common Stock | 1,864,290 | 09 Jan 2026 | Through Sero Capital LLC | F2 |
| Id | Content |
|---|---|
| F1 | Represents shares withheld to cover tax withholding obligations upon the vesting of restricted stock units. |
| F2 | Securities of the Issuer held directly by Sero Capital LLC ("Sero Capital"). David Moradi is the Managing Partner of Sero Capital and may be deemed to direct all voting and investment decisions made by Sero Capital. |